Cooley To Steer Vir Biotechnology's $150M IPO
Vir Biotechnology, which focuses on immunologic treatments for infectious diseases, said Monday it plans to raise $150 million in an initial public offering steered by Cooley LLP....To view the full article, register now.
Already a subscriber? Click here to view full article